152 related articles for article (PubMed ID: 33560084)
21. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
22. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
Smith GA; Damon LE; Rugo HS; Ries CA; Linker CA
J Clin Oncol; 1997 Feb; 15(2):833-9. PubMed ID: 9053511
[TBL] [Abstract][Full Text] [Related]
23. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
[TBL] [Abstract][Full Text] [Related]
24. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.
Segot A; Raffoux E; Lengline E; Thieblemont C; Dombret H; Boissel N; Cluzeau T
Ann Hematol; 2015 Nov; 94(11):1859-63. PubMed ID: 26280395
[TBL] [Abstract][Full Text] [Related]
25. Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.
Giles F; Vey N; DeAngelo D; Seiter K; Stock W; Stuart R; Boskovic D; Pigneux A; Tallman M; Brandwein J; Kell J; Robak T; Staib P; Thomas X; Cahill A; Albitar M; O'Brien S
Blood; 2009 Nov; 114(19):4027-33. PubMed ID: 19710500
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in acute myeloid leukemia patients.
Tangchitpianvit K; Rattarittamrong E; Chai-Adisaksopha C; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Tantiworawit A; Norasetthada L
Hematology; 2021 Dec; 26(1):355-364. PubMed ID: 33853503
[TBL] [Abstract][Full Text] [Related]
27. Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
Jurczak W; Kroll-Balcerzak R; Giebel S; Machaczka M; Giza A; Ogórka T; Fornagiel S; Rybka J; Wróbel T; Kumiega B; Skotnicki AB; Komarnicki M
Med Oncol; 2015 Apr; 32(4):90. PubMed ID: 25716885
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia.
Pugliese N; Salvatore P; Iula DV; Catania MR; Chiurazzi F; Della Pepa R; Cerchione C; Raimondo M; Giordano C; Simeone L; Caruso S; Pane F; Picardi M
Cancer Med; 2017 Jul; 6(7):1500-1511. PubMed ID: 28556623
[TBL] [Abstract][Full Text] [Related]
29. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
[TBL] [Abstract][Full Text] [Related]
30. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.
Magina KN; Pregartner G; Zebisch A; Wölfler A; Neumeister P; Greinix HT; Berghold A; Sill H
Blood; 2017 Aug; 130(7):946-948. PubMed ID: 28679736
[No Abstract] [Full Text] [Related]
31. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
[TBL] [Abstract][Full Text] [Related]
32. Bacteremia in febrile cancer patients in Uganda.
Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
[TBL] [Abstract][Full Text] [Related]
33. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
[TBL] [Abstract][Full Text] [Related]
34. Cytarabine dose for acute myeloid leukemia.
Löwenberg B; Pabst T; Vellenga E; van Putten W; Schouten HC; Graux C; Ferrant A; Sonneveld P; Biemond BJ; Gratwohl A; de Greef GE; Verdonck LF; Schaafsma MR; Gregor M; Theobald M; Schanz U; Maertens J; Ossenkoppele GJ;
N Engl J Med; 2011 Mar; 364(11):1027-36. PubMed ID: 21410371
[TBL] [Abstract][Full Text] [Related]
35. [Infection control in neutropenia induced by high-dose cytarabine chemotherapy].
Miyazaki M; Senzaki K; Kiyoi H; Kohno S; Noda Y; Nabeshima T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2011-5. PubMed ID: 15570930
[TBL] [Abstract][Full Text] [Related]
36. Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
Jirasek MA; Herrington JD
J Oncol Pharm Pract; 2016 Dec; 22(6):795-800. PubMed ID: 26419692
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
[TBL] [Abstract][Full Text] [Related]
38. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.
Paganini H; Staffolani V; Zubizarreta P; Casimir L; Lopardo H; Luppino V
Eur J Cancer; 2003 Jun; 39(9):1284-9. PubMed ID: 12763218
[TBL] [Abstract][Full Text] [Related]
39. Two cases of cytarabine syndrome successfully resolved by desensitization.
Lim KH; Kim JY; Kang MG; Park HK; Kang HR
J Investig Allergol Clin Immunol; 2015; 25(1):80-2. PubMed ID: 25898709
[No Abstract] [Full Text] [Related]
40. Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy: A Multicenter, Prospective, Observational Study in China.
Wang L; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Medicine (Baltimore); 2016 Jan; 95(4):e2560. PubMed ID: 26825897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
